ASPACELL, created in 2014 (France), from 8 sister brands and 2214 competing brands. ASPACELL is owned by ERYTECH Pharma, listed on the stock exchange of Paris The International Securities Identification Number (ISIN) of ERYTECH Pharma is FR0011471135. ASPACELL belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
ERYTECH Pharma
(ASPACELL)
over 5 years*
EUR 0.12